RODMAN&RENSHAW Stock Recommendations and Price Targets

This is a list of recent ratings by RODMAN&RENSHAW.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
1/28/2025
TLPH
Talphera
Upgrade$1.00Strong-BuyMedium
1/28/2025
CRDL
Cardiol Therapeutics
Upgrade$1.00Strong-BuyLow
1/28/2025
PYPD
PolyPid
Upgrade$3.00Strong-BuyHigh
1/28/2025
INMB
INmune Bio
Upgrade$9.00Strong-BuyHigh
1/28/2025
INDV
Indivior
Upgrade$10.00Strong-BuyLow
1/21/2025
ATRA
Atara Biotherapeutics
Downgrade$9.00Strong-Buy ➝ HoldMedium
12/20/2024
ATRA
Atara Biotherapeutics
Upgrade$9.00Strong-BuyN/A
12/19/2024
HURA
TuHURA Biosciences
Upgrade$4.00Strong-BuyN/A
12/6/2024
THAR
Tharimmune
Upgrade$2.00Strong-BuyN/A
11/14/2024
ADIL
Adial Pharmaceuticals
Upgrade$1.00Strong-BuyN/A
11/14/2024
RMTI
Rockwell Medical
Upgrade$2.00Strong-BuyN/A
11/14/2024
EPRX
Eupraxia Pharmaceuticals
Upgrade$3.00Strong-BuyN/A
11/14/2024
ACHV
Achieve Life Sciences
Upgrade$3.00Strong-BuyN/A
11/14/2024
OMER
Omeros
Upgrade$9.00Strong-BuyN/A
11/5/2024
BCAX
Bicara Therapeutics
Upgrade$13.00Strong-BuyLow
10/29/2024
QNCX
Quince Therapeutics
Upgrade$1.00Strong-BuyHigh
10/23/2024
ANRO
Alto Neuroscience
Downgrade$3.00Strong-Buy ➝ HoldMedium
10/9/2024
NKTX
Nkarta
Upgrade$2.00Strong-BuyHigh
10/9/2024
KYTX
Kyverna Therapeutics
Upgrade$3.00Strong-BuyHigh
9/30/2024
MIRA
MIRA Pharmaceuticals
Upgrade$1.00Strong-BuyLow
9/26/2024
BMEA
Biomea Fusion
Upgrade$4.00Strong-BuyLow




Get Analyst Ratings Delivered To Your Inbox
Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat's FREE daily email newsletter.